---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-043215"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:00:41.259655+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics Chair Frederick Wasserman to not stand for reelection at 2022 Annual Meeting

## Summary
- Frederick Wasserman, Chair of the Board, will not stand for reelection at the 2022 Annual Meeting.
- He has served on the Board since January 2016 and will continue in his roles until the meeting conclusion.
- His decision is not based on any disagreement with the Company or its management.
- No replacement for the Chair or director position has been announced yet.

## SEC filing metadata
- accession: 0001104659-22-043215
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465922043215/0001104659-22-043215-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465922043215/tm2211712d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-043215
- JSON: https://secwatch.observer/filing/0001104659-22-043215.json
- Plain text: https://secwatch.observer/filing/0001104659-22-043215.txt

## Key facts
- Executive change
  Frederick Wasserman departed as Chair of the Board at Marker Therapeutics, Inc..
  - Action: will not stand for reelection
  - Role: Chair of the Board
  source text: On April 5, 2022, Mr. Frederick Wasserman, a member of the board of directors (the “Board”) of Marker Therapeutics, Inc. (the “Company”), notified the Board that he will not stand for reelection as a director of the Company upon expiration of his current term.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1094038/000110465922043215/0001104659-22-043215-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.